
Ocular Therapeutix
@OCUTX
Followers
769
Following
106
Media
790
Statuses
845
Ocular Therapeutix, Inc. is a biopharmaceutical company committed to redefining the retina experience across drug development, treatment, and outcomes.
Bedford, MA
Joined November 2016
We enjoyed sharing updates from our SOL and HELIOS clinical trials at @CTS_Tahoe. Our conversations were inspiring, and we’re energized to continue working to redefine the retina experience. Thanks to everyone who made it such a memorable meeting!. #CTS2025 #RetinaRedefined
0
0
0
We're excited for @CTS_Tahoe, where Peter Kaiser, MD, and Jeff Heier, MD, will serve as co-chairs. We’ll present updates on our SOL and HELIOS trials and discuss our mission to redefine the retina experience. Learn more: #CTS2025 #RetinaRedefined
1
2
7
Thank you to those who joined us at @RetinaWCongress! We enjoyed sharing updates on our clinical trials, presenting at Retina Unplugged, and connecting with everyone who visited our booth and at other congress events. . #RetinaWorldCongress #RetinaRedefined
1
1
3
Ocular's Executive Chairman, President, and CEO, Pravin Dugel, MD, will participate in several upcoming fireside chats. Tune in to hear more about Ocular’s mission to redefine the retina experience.. Learn more: #RetinaRedefined #Retina
0
0
1
Our team had an incredible time at the @ARVOinfo meeting! We appreciate the opportunity to sponsor this important congress and connect with the retina community. We look forward to the journey ahead as we aim to redefine the retina experience. #ARVO2025 #RetinaRedefined #Retina
0
0
2
We're looking forward to attending the annual @RetinaWCongress, taking place May 8-11, where we'll share exciting updates on our clinical trials and explore the latest retina innovations. Stop by booth 2 to learn more. #RetinaWorldCongress #RetinaRedefined #WetAMD
0
0
1
Today, we shared our Q1 2025 financial results and the latest updates on our registrational SOL program for wet age-related macular degeneration. Learn more: #RetinaRedefined
0
0
1
We're excited to attend the @ARVOinfo Annual Meeting, taking place from May 4-8 in Salt Lake City, UT. Our team can’t wait to discuss updates on our clinical trials as we aim to redefine the retina experience.. #ARVO2025 #RetinaRedefined #Retina
0
1
2
We’re looking forward to the Citizens JMP and Bank of America Healthcare Conferences, where our Executive Chairman, President, and CEO, Pravin Dugel, MD, will discuss Ocular’s mission to redefine the retina experience. Hear more: #RetinaRedefined
0
0
0
Our team looks forward to attending the Piper Sandler Spring Biopharma Symposium on April 17 in Boston, MA. We are excited to connect with healthcare leaders and share the latest updates on how we’re redefining the retina experience.. #RetinaRedefined
0
0
0
We look forward to discussing our mission to redefine the retina experience at the COPHy Congress in Seville, Spain. We are excited about the debate on sustained drug delivery options and the symposium on extending durability with OTX-TKI.. #COPHY2025 #RetinaRedefined
0
0
1
We had a fantastic time at the Wild Wild @VitBuckleSoc Congress in Austin, TX. Our team gained valuable insights from engaging with retina specialists and attending insightful sessions. . #RetinaRedefined #WetAMD
0
0
0
Our team will be in Austin, TX, for the 13th Annual @VitBuckleSoc Meeting, featuring cutting-edge discussions, innovative presentations, and networking opportunities with leading experts.. #RetinaRedefined #WetAMD #DiabeticRetinopathy
0
0
0
We had an incredible experience at the Retina Consultants of America 2025 Meeting! Our team was thrilled to share how we are redefining the retina experience and engage with so many passionate retina specialists and the entire research staff.. #RetinaRedefined #WetAMD
0
0
1
Ocular Therapeutix will be attending the Retina Consultants of America 2025 Meeting to share how our team is working to redefine the retina experience. We look forward to presenting on March 7 at 12:05 and 1:00 PM MT. We'll see you there!. #RetinaRedefined #WetAMD
0
0
1
Today, we announced our Q4 2024 financial results, and Pravin Dugel, Ocular's Executive Chairman, President, and CEO, provided key updates on the registrational SOL program for wet age-related macular degeneration. Find out more here: #RetinaRedefined
0
0
1
Ocular is excited to attend the Aspen Retinal Detachment Society meeting in Snowmass, CO! We look forward to engaging with fellow professionals and sharing how Ocular is redefining the retina experience. . #ARDS2025 #RetinaRedefined #WetAMD
0
1
1
We're excited to participate in the upcoming TD Cowen and Leerink Partners Annual Health Care Conferences! Tune in to the webcasts to hear the fireside chats for updates on our progress in redefining the retina experience. . Learn more: #RetinaRedefined
0
0
0
We're excited to share the release of our Q4 earnings on March 3, when we’ll share our financial results for the fourth quarter of 2024. . Learn more: . #RetinaRedefined
1
0
0